Get the Stockscreener App
27.18
5.10%
1.32
Vtv Therapeutics Inc stock is traded at $27.18, with a volume of 8,230.
It is up +5.10% in the last 24 hours and up +9.07% over the past month.
vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin, currently in a Phase 3 trial, a potential novel first-in-class oral liver-selective glucokinase activator being investigated for the treatment of type 1 diabetes. The group and its development partners are investigating multiple molecules across different indications for chronic diseases. Its product pipeline are HPP737, Azeliragon, TTP-RA, TTP273, HPP971 / HPP3033, and HPP593.
See More
Previous Close:
$25.86
Open:
$25.9766
24h Volume:
8,230
Relative Volume:
1.10
Market Cap:
$107.04M
Revenue:
$17,000
Net Income/Loss:
$-23.87M
P/E Ratio:
-8.7115
EPS:
-3.12
Net Cash Flow:
$-22.03M
1W Performance:
+0.67%
1M Performance:
+9.07%
6M Performance:
+69.88%
1Y Performance:
+64.33%
1-Day Range:
$25.98
$27.68
1-Week Range:
$22.91
$27.68
52-Week Range:
$13.15
$33.16
Vtv Therapeutics Inc Stock (VTVT) Company Profile
Name
Vtv Therapeutics Inc
Sector
Industry
Phone
336-841-0300
Address
3980 PREMIER DR, HIGH POINT, NC
Compare VTVT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTVT
Vtv Therapeutics Inc
|
27.18 | 101.84M | 17,000 | -23.87M | -22.03M | -3.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-19-25 | Initiated | BTIG Research | Buy |
| May-30-19 | Initiated | H.C. Wainwright | Buy |
| Apr-10-18 | Downgrade | Stifel | Buy → Hold |
| Mar-08-18 | Initiated | ROTH Capital | Buy |
| Feb-08-18 | Initiated | Northland Capital | Outperform |
| Sep-26-16 | Initiated | H.C. Wainwright | Buy |
| Sep-04-15 | Initiated | Canaccord Genuity | Buy |
| Aug-24-15 | Initiated | Piper Jaffray | Overweight |
| Aug-24-15 | Initiated | Stifel | Buy |
View All
Vtv Therapeutics Inc Stock (VTVT) Latest News
How vTv Therapeutics Inc. (5VT0) stock moves in volatile trading sessionsJuly 2025 PostEarnings & Free Real-Time Volume Trigger Notifications - Newser
Can vTv Therapeutics Inc. (5VT0) stock hit consensus price targetsMarket Risk Analysis & Long-Term Safe Investment Ideas - Newser
Why vTv Therapeutics Inc. stock is a must watch in 20252025 Key Highlights & High Accuracy Buy Signal Tips - Newser
Is vTv Therapeutics Inc. stock resilient to inflationSell Signal & Stock Market Timing Techniques - Newser
How dovish Fed policy supports vTv Therapeutics Inc. (5VT0) stockTrade Ideas & Free Verified High Yield Trade Plans - Newser
What makes vTv Therapeutics Inc. (5VT0) stock appealing to growth investorsTrade Risk Assessment & Daily Technical Forecast Reports - Newser
Published on: 2025-12-03 00:26:57 - Newser
Liquidity Mapping Around (VTVT) Price Events - news.stocktradersdaily.com
Why vTv Therapeutics Inc. stock remains a top recommendationJuly 2025 Catalysts & Weekly High Momentum Picks - Newser
What technical patterns form on vTv Therapeutics Inc. (5VT0) stock chartsQuarterly Risk Review & Safe Capital Growth Stock Tips - Newser
Here's Why We're Not Too Worried About vTv Therapeutics' (NASDAQ:VTVT) Cash Burn Situation - Sahm
Will vTv Therapeutics Inc. (5VT0) stock attract long term capital inflowsJuly 2025 Outlook & High Accuracy Trade Alerts - Newser
Why analysts remain bullish on vTv Therapeutics Inc. stock2025 Top Gainers & AI Enhanced Trading Alerts - Newser
Is vTv Therapeutics Inc a good long term investmentEarnings Call Summaries & Fast Growing Trading Ideas - earlytimes.in
What drives vTv Therapeutics Inc stock priceTake Profit Strategies & Exceptional Growth Portfolio - earlytimes.in
vTv Therapeutics (NASDAQ:VTVT) Shares Pass Above 50-Day Moving AverageHere's Why - MarketBeat
[EFFECT] vTv Therapeutics Inc. SEC Filing - Stock Titan
Does vTv Therapeutics (VTVT) Have the Potential to Rally 25.17% as Wall Street Analysts Expect? - sharewise.com
Why (VTVT) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
vTv Therapeutics (NASDAQ:VTVT) Raised to Strong-Buy at BTIG Research - MarketBeat
vTv Therapeutics (NASDAQ:VTVT) Upgraded at BTIG Research - Defense World
BTIG Research Initiates Coverage on vTv Therapeutics (NASDAQ:VTVT) - MarketBeat
Is vTv Therapeutics Inc. (5VT0) stock included in top ETFs2025 Historical Comparison & Entry Point Strategy Guides - newser.com
Why retail investors favor vTv Therapeutics Inc. stock2025 Price Action Summary & Weekly Consistent Profit Watchlists - newser.com
Will vTv Therapeutics Inc. (5VT0) stock beat international competitionBond Market & Long-Term Safe Investment Plans - newser.com
What makes vTv Therapeutics Inc. stock attractive to growth fundsPortfolio Value Report & Low Risk High Win Rate Stock Picks - newser.com
Can vTv Therapeutics Inc. stock sustain market leadershipJuly 2025 Spike Watch & Low Risk High Win Rate Stock Picks - newser.com
How vTv Therapeutics Inc. (5VT0) stock benefits from digital adoptionShort Setup & Weekly Chart Analysis and Guides - newser.com
Will vTv Therapeutics Inc. (5VT0) stock justify high valuationJuly 2025 Gainers & Safe Capital Growth Stock Tips - newser.com
Has vTv Therapeutics Inc. found a price floorWatch List & Free Expert Verified Stock Movement Alerts - newser.com
BTIG Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $40 - 富途牛牛
BTIG Initiates Coverage of vTv Therapeutics (VTVT) with Buy Recommendation - Nasdaq
Will vTv Therapeutics Inc. stock deliver consistent dividends2025 Support & Resistance & Daily Oversold Bounce Ideas - newser.com
Can vTv Therapeutics Inc. (5VT0) stock attract ESG investmentsQuarterly Earnings Report & Weekly Consistent Profit Watchlists - newser.com
BTIG Initiates Coverage on vTv Therapeutics (VTVT) with a "Buy" Rating | VTVT Stock News - GuruFocus
Is vTv Therapeutics Inc. (5VT0) stock supported by strong fundamentalsQuarterly Trade Review & Weekly Market Pulse Updates - newser.com
Why vTv Therapeutics Inc. stock is recommended by analystsAnalyst Downgrade & Verified Momentum Stock Ideas - newser.com
Vtv Therapeutics Inc Stock (VTVT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):